Beaufort County Memorial Hospital

CLIA Laboratory Citation Details

2
Total Citations
6
Total Deficiencyies
5
Unique D-Tags
CMS Certification Number 42D0950004
Address 989 Ribaut Road, Beaufort, SC, 29902-5472
City Beaufort
State SC
Zip Code29902-5472
Phone843 522-7330
Lab DirectorBRADFORD COLLINS

Citation History (2 surveys)

Survey - August 12, 2026

Survey Type: Standard

Survey Event ID: RO9D11

Deficiency Tags: D0000 D5217 D5293

Summary:

Summary Statement of Deficiencies D0000 An announced onsite CLIA recertification survey was conducted on August 12, 2026 at the laboratory of Beaufort Memorial Medical Oncology Infusion Center by the South Carolina Department of Public Health (SC DPH) Bureau of Nursing Homes and Medical Services. The laboratory was found to be out of compliance with conditions of participation for the Clinical Laboratory Improvement Amendments (CLIA) of 1988 requirements found at 42 CFR Part 493. The following is a list of STANDARD LEVEL deficiencies cited as a result of the recertification survey of August 12, 2026. D5217 EVALUATION OF PROFICIENCY TESTING PERFORMANCE CFR(s): 493.1236(c)(1) At least twice annually, the laboratory must verify the accuracy of any test or procedure it performs that is not included in subpart I of this part. This STANDARD is not met as evidenced by: Based on review of "Quality Management Plan", lack of documentation, and staff interview, the laboratory failed to document twice annual check of the laboratory information system (LIS). Findings included: 1. CLIA regulations require twice annual verification of accuracy of laboratory systems. 2. Review of laboratory's "Quality Management Plan" reveals the requirement of performance and documentation of twice annual verification of the LIS performance. 3. In an interview with the technical consultant (TC) on August 12, 2026 at 1:00pm in the laboratory, the findings were confirmed. D5293 GENERAL LABORATORY SYSTEMS QUALITY ASSESSMENT CFR(s): 493.1239(b)(c) (b) The general laboratory systems quality assessment must include a review of the effectiveness of

πŸ”’ Unlock Deficiency Summary

Get full access to the detailed deficiency summary for this facility

One-time payment β€’ Lifetime access

Survey - August 23, 2024

Survey Type: Standard

Survey Event ID: M7HB11

Deficiency Tags: D5413 D6013 D0000

Summary:

Summary Statement of Deficiencies D0000 An onsite CLIA recertification survey was conducted on August 23, 2024 by the South Carolina Department of Public Health's (SC DPH) Bureau of Nursing Homes and Medical Services at the clinical laboratory of Beaufort Memorial Oncology. The laboratory was found to be out of compliance 42 CFR Part 493, CLIA Requirements for Laboratories The following is a description of the Stanard Level Deficiencies cited: D5413 TEST SYSTEMS, EQUIPMENT, INSTRUMENTS, REAGENT CFR(s): 493.1252(b) The laboratory must define criteria for those conditions that are essential for proper storage of reagents and specimens, accurate and reliable test system operation, and test result reporting. The criteria must be consistent with the manufacturer's instructions, if provided. These conditions must be monitored and documented and, if applicable, include the following: (1) Water quality. (2) Temperature. (3) Humidity. (4) Protection of equipment and instruments from fluctuations and interruptions in electrical current that adversely affect patient test results and test reports. This STANDARD is not met as evidenced by: Based on the lack of documentation, direct observation, and staff interview, the laboratory failed to monitor the temperature and humidity of the laboratory environment. Findings included: 1. Review of laboratory documentation reveals temperature measurements for the laboratory area. 2. No documentation for environmental monitoring was available for the two (2) phlebotomy drawing rooms. Blood collection tubes were stored in these 2 rooms. 3. During a tour of the laboratory and phlebotomy drawing rooms, the surveyor noted the lack of environmental monitoring devices in the phlebotomy drawing rooms. 4. In a staff interview on August 23, 2024, at 1:30pm in the laboratory with technical consultant (TC), the findings were confirmed. Statement of Deficiencies (X1) Provider/Supplier/CLIA Identification Number (X3) Date Survey Completed Name of Provider or Supplier Street Address, City, State -- 1 of 2 -- D6013 LABORATORY DIRECTOR RESPONSIBILITIES CFR(s): 493.1407(e)(3)(ii) The laboratory director is responsible for the overall operation and administration of the laboratory, including the employment of personnel who are competent to perform test procedures, and record and report test results promptly, accurate, and proficiently and for assuring compliance with the applicable regulations. (e) The laboratory director must-- (e)(3) Ensure that-- (e)(3)(ii) Verification procedures used are adequate to determine the accuracy, precision, and other pertinent performance characteristics of the method; This STANDARD is not met as evidenced by: Based on the lack of documentation, direct observation and staff interview, The laboratory director failed to ensure that an approved procedure manual is available to all personnel responsible for any aspect of the testing process. Findings included: 1. Review of laboratory documentation reveals the lack written policy and procedures for the following: a. Performance and documentation of Quality Controls. b. Performance and documentation of Quality Assurance monitors. c. Performance and documentation of Proficiency Testing. 2. By document review, the surveyor recognized that the laboratory was using the manufacturer's instructions on how to perform testing on the DxH 520 hematology analyzer and the Abbott Piccolo chemistry instrument. 3. Document review reveals no evidence review or sign off by the laboratory director for the above mentioned procedures. 4 In a staff interview with the TC on August 23, 2024 at 1;30pm in the laboratory, the findings were confirmed. -- 2 of 2 --

πŸ”’ Unlock Deficiency Summary

Get full access to the detailed deficiency summary for this facility

One-time payment β€’ Lifetime access